Omega Healthcare Investors (NYSE:OHI - Get Free Report) had its price objective reduced by stock analysts at Wells Fargo & Company from $39.00 to $38.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an "equal weight" rating on the real estate investment trust's stock. Wells Fargo & Company's price target indicates a potential upside of 1.47% from the company's current price.
A number of other equities research analysts have also recently weighed in on the stock. JMP Securities restated a "market perform" rating on shares of Omega Healthcare Investors in a report on Friday, February 7th. Truist Financial raised their price target on Omega Healthcare Investors from $38.00 to $39.00 and gave the company a "hold" rating in a report on Tuesday, March 18th. Six equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat, Omega Healthcare Investors presently has a consensus rating of "Hold" and a consensus price target of $41.88.
Check Out Our Latest Stock Report on Omega Healthcare Investors
Omega Healthcare Investors Stock Performance
NYSE:OHI traded up $0.34 during trading hours on Monday, reaching $37.45. The stock had a trading volume of 2,242,538 shares, compared to its average volume of 2,385,774. The stock has a market cap of $10.84 billion, a P/E ratio of 24.16, a price-to-earnings-growth ratio of 1.09 and a beta of 0.73. The stock has a 50 day simple moving average of $37.24 and a 200 day simple moving average of $37.64. The company has a debt-to-equity ratio of 1.02, a quick ratio of 7.07 and a current ratio of 7.07. Omega Healthcare Investors has a 12-month low of $31.43 and a 12-month high of $44.42.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The real estate investment trust reported $0.75 earnings per share for the quarter, meeting the consensus estimate of $0.75. The firm had revenue of $228.38 million for the quarter, compared to analysts' expectations of $236.61 million. Omega Healthcare Investors had a return on equity of 9.71% and a net margin of 38.65%. The company's revenue was up 13.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.68 earnings per share. On average, research analysts forecast that Omega Healthcare Investors will post 2.86 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in OHI. Stonebridge Financial Group LLC purchased a new stake in Omega Healthcare Investors in the 4th quarter worth approximately $26,000. NBC Securities Inc. bought a new position in shares of Omega Healthcare Investors during the first quarter worth $29,000. Kentucky Trust Co bought a new position in shares of Omega Healthcare Investors during the fourth quarter worth $38,000. V Square Quantitative Management LLC grew its stake in Omega Healthcare Investors by 44.5% during the fourth quarter. V Square Quantitative Management LLC now owns 1,410 shares of the real estate investment trust's stock valued at $53,000 after acquiring an additional 434 shares in the last quarter. Finally, Loomis Sayles & Co. L P lifted its stake in Omega Healthcare Investors by 27.6% in the 4th quarter. Loomis Sayles & Co. L P now owns 1,475 shares of the real estate investment trust's stock worth $56,000 after purchasing an additional 319 shares in the last quarter. Institutional investors own 65.25% of the company's stock.
About Omega Healthcare Investors
(
Get Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Recommended Stories

Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.